An implementation study recently published in The Lancet examined the clinical utility of a 12-gene pharmacogenetic (PGx) panel to reduce adverse drug reactions throughout Europe. The PREPARE study represents the first
Translational Software attended the 2020 PMWC (Precision Medicine World Conference) in Silicon Valley last month. Turnout has grown from when we first attended back in 2012, where all attendees could fit into one
The 5th International Congress of the European Society of Pharmacogenomics and Personalized Therapy (ESPT 2019) was held inSeville, Spain, from Oct. 16-18, 2019. The conference addressed the research progress and
Pharmacogenomics promises to offer better treatment outcomes, fewer side effects, and a more personalized healthcare experience. To deliver on this promise, PGx must reach a wide audience, not just those with the
Most PGx programs operate in large academic medical centers within densely populated urban areas. These communities are often already rich in healthcare resources. But what about more rural populations?